Even after three big losses in court trials and a plunge in market value, Bayer AG isn’t close to settling tens of thousands of U.S. lawsuits claiming its Roundup weedkiller causes cancer, according to a lawyer who won one of those cases.
 
Aimee Wagstaff, who helped persuade a jury to award $80 million in damages to a Roundup user earlier this year, said more trials loom in 2020 and Bayer “doesn’t care” that its Monsanto unit lost her case, or the other two. Wagstaff declined to elaborate, though Bayer has insisted publicly Roundup is safe. The German company has appealed the trial losses and said it will continue the fight in court.
 
“I wouldn’t expect any settlement in the near future,” Wagstaff, a Denver-based attorney, told a group of plaintiffs’ lawyers at a Las Vegas convention Oct. 23. “This litigation is far from being over.” She didn’t return phone calls and an email Tuesday seeking additional comment.
 
Bayer has lost more than $30 billion in value since last year’s $63 billion purchase of Roundup creator Monsanto Co. The deal put Bayer Chief Executive Officer Werner Baumann on the hot seat as claims against the weedkiller escalated, raising concern from investors about the cost of resolving the litigation.
 
Click Here to read more.